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individuals infected by any new agent will have health and eco-
nomic beneﬁts.
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OBJECTIVES: To quantify the impact of tension headache on
work productivity loss and activity impairment of adults aged 18
to 64 in 5 European countries. METHODS: We analyzed data
from the 2007 European National Health and Wellness Survey
(NHWS), an annual, cross-sectional study of adults (aged 18+)
in France, Germany, Italy, Spain, and the UK. NHWS data were
collected via self-administered, Internet-based questionnaires.
The analysis sample consisted of respondents aged 18 to 64, who
reported three or more tension headaches in the past month. The
control group included respondents who did not experience
any types of headache in the past year. Work productivity loss
and activity impairment were assessed using the general health
version of the Work Productivity and Activity Impairment
(WPAI) questionnaire. Linear regression models were developed
to adjust for gender, age, country of residence, number of physi-
cal comorbid conditions, and presence of a psychiatric condition.
RESULTS: Across the ﬁve countries, there were a total of 5,144
(20.1%) adults with tension headaches and 20,453 (79.9%)
controls. Adults with tension headaches were signiﬁcantly more
likely to be female, younger, reside in Germany or the UK, have
a greater number of physical comorbid conditions, and have a
psychiatric condition than adults without headaches (p < 0.001
for all). Adjusting for demographics and comorbidity, adults with
tension headaches who worked full-time experienced 4.93%
greater impairment while working (presenteeism), and 4.86%
greater overall work impairment than controls (p < 0.001 for
both). Missed work time (absenteeism) was not signiﬁcantly
affected by tension headache. Overall, adults with tension head-
aches experienced 6.21% greater activity impairment than con-
trols (p < 0.001). CONCLUSIONS: The study results showed
signiﬁcant reduction in productivity in patients with tension
headaches. Because patients often self-medicate patient reported
outcomes may help employers and payers to better understand
and manage the disease.
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OBJECTIVES: To evaluate how abdominal obesity (AO) mea-
sured by waist circumference (WC) affects productivity and
indirect costs over 3 months in a population of overweight and
obese (25  BMI  35 kg/m2) subjects in the US and Germany.
METHODS: Subjects were recruited by the internet; 5410 (US)
and 5406 (Germany) eligible and consented subjects were
stratiﬁed by BMI and gender into normal weight (BMI
20–24.9, n = 404), overweight (BMI 25–29.9, n = 8009), and
obese (BMI 30–35 kg/m2, n = 1403) groups. Weight, height and
WC were self reported and validated. In overweight and obese
groups, subjects were further classiﬁed into high and low WC
groups using the observed gender-speciﬁc median WC. Impair-
ment at work among employed respondents (presenteeism)
was assessed using the validated questionnaire WPAI, General
Health version. Absenteeism was assessed based on self-
reported number of days missed from work due to a health
problem in the past 3 months. Indirect costs were calculated by
adding cost of absenteeism and presenteeism (both monetized
by using country speciﬁc estimated quarterly earnings).
RESULTS: The percentage of subjects in each group working
for pay (low/high WC respectively) were 70%/62% (over-
weight), 64%/55% (obese) in the US; and 73%/66% (over-
weight), 67%/56% (obese) in Germany. In both countries and
overweight/obese groups, subjects above median WC had a sig-
niﬁcantly higher mean percent of overall impairment while
working than subjects with low WC. In both countries, except
for obese German, subjects with high WC had a signiﬁcantly
higher mean indirect cost than subjects with low WC (low, high
WC, respectively); in US: $804, $1070 in overweight subjects
and $958, $1391 in obese subjects; in Germany: €907, €1095
in overweight subjects and €1178, €1352 in obese subjects.
CONCLUSIONS: Within each overweight and obese group,
subjects with high WC had a 7% to 11% lower employment
rate, signiﬁcant overall impairment at work and consequently
higher indirect costs.
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OBJECTIVES: To estimate the health care burden of patients in
UK primary care with a diagnosis of ﬁbromyalgia, a chronic
pain disorder characterised by widespread pain, sleep distur-
bance, fatigue, anxiety and depression. METHODS: The CSD
Patient Data database was used to identify a cohort of patients
presenting with ﬁbromyalgia (FM) during 2006. Each patient
was randomly matched by age and sex to one control patient
with no FM, in the same GP practice. Consultations, prescrip-
tions, hospital referrals, hospital admissions, sick notes, and
alternative therapy were compared for the 12 months following
the FM diagnosis. RESULTS: Each cohort contained 1033
patients: most (82%) were aged 35–64, and 88% were female.
Twenty-ﬁve percent of the FM cohort was newly diagnosed
with FM during 2006; 75% had pre-existing FM. Compared to
the control cohort, 37% of the FM cohort had a major adverse
event (versus 17%); 24% of the FM cohort had aches/pains
(versus 11%). Headache/migraine, depression, and sleep prob-
lems were also more prevalent in the FM cohort. Patients in the
FM cohort were issued 51 prescriptions in the tracking year
(versus 16 prescriptions for the controls), and consulted their
GP 15 times in the year (8 times for the controls). Compared to
the controls, twice as many patients in the FM cohort were
referred to hospital, and 50% more FM patients were issued
a sick note by their GP. Importantly, less than 50% of this
additional resource use could be speciﬁcally attributed to FM.
CONCLUSIONS: UK patients diagnosed with ﬁbromyalgia
present a considerably greater burden to the UK NHS than
patients without FM. In addition, less than 50% of this addi-
tional burden can be attributed to FM, suggesting that patients
with FM suffer much greater co-morbidity alongside their con-
dition. Future research should evaluate the ﬁnancial impact of
this additional burden to the UK NHS.
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